Cancer immunotherapy: predict outcomes better with combination biomarkers

Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. In this series of lectures, I present IMPRES and TIDE, two of the best predictors of cancer immunotherapy outcomes. I also show an easy way to combine them and improve their predictions, using a combination biomarker. Finally, I make suggestions of practical ways to contribute to research on this topic. Speaker: Mostapha Benhenda, bioinformatician at Melwy.com You will receive the link to the lectures by registering to this event.

09/17/2019


07:00 PM

Interests

Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.

Advertisement
Advertisement
Advertisement